한방 뇌졸중 치료제 비에치티 구강붕해정의 약제학적 조성물 및 제조방법
    11.
    发明公开
    한방 뇌졸중 치료제 비에치티 구강붕해정의 약제학적 조성물 및 제조방법 有权
    含有中国医药BHT的ORALY DISCETTINGS TABLET的药物组合物及其制备方法

    公开(公告)号:KR1020110049993A

    公开(公告)日:2011-05-13

    申请号:KR1020090106793

    申请日:2009-11-06

    Abstract: PURPOSE: A pharmaceutical composition of BHT orally disintegrating tablet is provided to maximize stroke treatment effect. CONSTITUTION: A pharmaceutical composition of BHT orally disintegrating tablet contains 30-50 weight% of dried extract, 15-50 weight% of crospovidone, 5-30 weight% of crushed Arabian gum, and 0.1-2 weight% of glyceryl behenate. The dried extract is a mixture extract of Paeoniae Radix, Angelicae Gigantis Radix, Persicae Semen, Carthami Flos, Cnidii Rhizoma, Cinnamomi Ramulus, earth worm, Salviae Radix, Astragali Radix, Achyranthis Radix, Acori graminei Rhizoma and Polygalae Radix. The orally disintegrating tablet additionally contains one of microcrystalline cellulose and spray-dried lactose.

    Abstract translation: 目的:提供BHT口服崩解片的药物组合物,以最大限度地提高卒中治疗效果。 构成:BHT口腔崩解片剂的药物组合物含有30-50重量%的干提取物,15-50重量%的交聚维酮,5-30重量%的压碎的阿拉伯胶和0.1-2重量%的山嵛酸甘油酯。 干燥的提取物是芍药,当归,茯苓,樟子松,蚯蚓,蚯蚓,丹参,黄芪,黄芪,芦荟和Polygalae的混合物提取物。 口腔崩解片还含有微晶纤维素和喷雾干燥的乳糖中的一种。

    신부전 예방 및 치료용 이중핵정
    12.
    发明公开
    신부전 예방 및 치료용 이중핵정 有权
    用于预防和治疗与失败相关的疾病的药物组合物的双核心片

    公开(公告)号:KR1020100128508A

    公开(公告)日:2010-12-08

    申请号:KR1020090046931

    申请日:2009-05-28

    Abstract: PURPOSE: A dual core tablet for preventing and treating renal insufficiency is provided to enhance and protect gastrointestinal movement and to maximize treatment effects. CONSTITUTION: A dual core tablet for preventing and treating renal insufficiency contains an enteric core tablet and gastric external tablet. An enteric coat is applied between the enteric core table and gastric external tablet. The enteric core tablet contains herb extract of Salviae miltiorrhizae radix, Pinelliae rhizome, Coptis rhizome, Evodiae fructus, Epimedii herba, Rhei radix et rhizome, and Polyporus. The gastric external tablet contains herb mixture extract of Codonopsis pilosulae radix, Perillae folium, Glycyrrhizae radix, Artemisiae capillaris herba, Alismatis rhizome, Poria, Atractylodis macrocephalae rhizome, and Cinnamomi ramulus.

    Abstract translation: 目的:提供用于预防和治疗肾功能不全的双核心片剂,以增强和保护胃肠道运动并最大限度地提高治疗效果。 构成:用于预防和治疗肾功能不全的双核心片剂包含肠溶片和胃外片。 在肠心外表和胃外片之间施用肠衣。 肠绞肉片含有丹参,山茶根,黄连,黄芩,淫羊藿,茯苓和多孔菌的草药提取物。 胃外片含有党参,紫菜叶,甘草,青蒿,阿拉斯他根,茯苓,白术,樟子松等植物混合提取物。

    한방 뇌졸중 치료제 비에치티 구강붕해정의 약제학적 조성물 및 제조방법
    15.
    发明授权
    한방 뇌졸중 치료제 비에치티 구강붕해정의 약제학적 조성물 및 제조방법 有权
    含有中药BHT的口腔崩解片的药物组合物及其制备方法

    公开(公告)号:KR101144613B1

    公开(公告)日:2012-05-11

    申请号:KR1020090106793

    申请日:2009-11-06

    Abstract: PURPOSE: A pharmaceutical composition of BHT orally disintegrating tablet is provided to maximize stroke treatment effect. CONSTITUTION: A pharmaceutical composition of BHT orally disintegrating tablet contains 30-50 weight% of dried extract, 15-50 weight% of crospovidone, 5-30 weight% of crushed Arabian gum, and 0.1-2 weight% of glyceryl behenate. The dried extract is a mixture extract of Paeoniae Radix, Angelicae Gigantis Radix, Persicae Semen, Carthami Flos, Cnidii Rhizoma, Cinnamomi Ramulus, earth worm, Salviae Radix, Astragali Radix, Achyranthis Radix, Acori graminei Rhizoma and Polygalae Radix. The orally disintegrating tablet additionally contains one of microcrystalline cellulose and spray-dried lactose.

    함량 모니터링을 이용한 천연물의 함량기준 설정 방법
    16.
    发明授权
    함량 모니터링을 이용한 천연물의 함량기준 설정 방법 有权
    建立草药中标记化合物浓度的限制

    公开(公告)号:KR101123081B1

    公开(公告)日:2012-03-16

    申请号:KR1020110030475

    申请日:2011-04-04

    Inventor: 강종성 장유선

    CPC classification number: G06F19/326 G06F17/10

    Abstract: PURPOSE: A method for setting concentration limit of natural product is provided to set up the concentration limit of natural product including herbal medicine by applying a regression line method to the natural product including herbal medicine. CONSTITUTION: Component content of a sample about natural product including herbal medicine is detected(S401). Cumulative probability distribution is calculated as percentile about component content(S403). Log content cumulative probability distribution sets up a natural log value as an independent variable(S404). A line regression tendency about log content cumulative probability distribution is drawn out by applying a straight line regression scheme(S407).

    Abstract translation: 目的:提供天然产物浓度限制的方法,通过对包括草药在内的天然产物采用回归线法,建立包括草药在内的天然产物的浓度限值。 检测方法(S401)检测有关天然产物(包括草药)的样品成分含量(S401)。 累积概率分布计算为关于分量内容的百分位数(S403)。 日志内容累积概率分布将自然对数值设置为独立变量(S404)。 通过应用直线回归方法绘制关于日志内容累积概率分布的线回归趋势(S407)。

Patent Agency Ranking